Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07418203
Brief Summary:
Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule.
Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV.
Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.
Detailed Description:
The main objective is to describe knowledge of girls and boys aged 18-19 about papillomavirus and HPV vaccination
Study:
NCT07418203
Study Brief:
Protocol Section:
NCT07418203